Negin Soroush

Negin Soroush is a Researcher affiliated with Erasmus MC in the Department of Epidemiology. Her work focuses on cardiovascular pharmacogenetics and pharmacoepidemiology, particularly exploring genetic factors influencing drug responses and disease outcomes. She has published extensively on topics including digoxin's effects, sudden cardiac death, and type 2 diabetes mellitus.

Research Interests: Her research integrates pharmacogenomics with epidemiological methods to study drug efficacy and safety. Key areas include genetic variants modifying drug responses (e.g., NOS1AP gene's role in digoxin-related arrhythmias), cardiovascular outcomes in diabetes, and biomarkers for arrhythmias. Her 2025 doctoral thesis highlights advancements in linking pharmacogenetic findings to clinical outcomes.

Collaborations: She collaborates internationally on large-scale studies like the genome-wide association study on cardiac arrhythmia biomarkers. Her work often involves multi-institutional teams analyzing genetic and clinical data from diverse populations. Recent studies emphasize translational applications of pharmacogenetic discoveries to improve personalized medicine.

Grants & Labs: While specific grants aren't listed, her publications suggest involvement in projects funded by institutions like Erasmus MC and collaborations with pharmaceutical researchers. She contributes to teams investigating vascular aging and drug metabolism mechanisms.